Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
University of Pennsylvania
H. Lee Moffitt Cancer Center and Research Institute
Hospices Civils de Lyon
AHS Cancer Control Alberta
H. Lee Moffitt Cancer Center and Research Institute
Institut Curie
Weill Medical College of Cornell University
Oslo University Hospital
Institute of Hematology & Blood Diseases Hospital, China
Washington University School of Medicine
Icahn School of Medicine at Mount Sinai
University of Arkansas
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Arbeitsgemeinschaft medikamentoese Tumortherapie
Second Affiliated Hospital, School of Medicine, Zhejiang University
University of Rochester
University of Rochester
Peter MacCallum Cancer Centre, Australia
Insel Gruppe AG, University Hospital Bern
M.D. Anderson Cancer Center
Peking Union Medical College Hospital
Amsterdam UMC, location VUmc
University of Leeds
International Myeloma Foundation
Weill Medical College of Cornell University
University of Nebraska
Singapore General Hospital
Sun Yat-sen University
Imperial College Healthcare NHS Trust
Insel Gruppe AG, University Hospital Bern
University Hospital, Clermont-Ferrand
Virginia Commonwealth University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
Hackensack Meridian Health
Herlev Hospital
Hellenic Society of Hematology
Hellenic Society of Hematology
Oxford University Hospitals NHS Trust
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Weill Medical College of Cornell University
University of Southampton
Icahn School of Medicine at Mount Sinai
Masonic Cancer Center, University of Minnesota